- Investing Ideas
- /
- Hong Kong Big Pharma, Big Dividends
Hong Kong Big Pharma, Big Dividends
Results
5
Large pharmaceutical stocks to buy with strong dividend features.
5 companies
CSPC Pharmaceutical Group
Market Cap: HK$101.3b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$8.86
7D
4.2%
1Y
96.5%
Sino Biopharmaceutical
Market Cap: HK$117.6b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$6.58
7D
4.8%
1Y
117.2%
Grand Pharmaceutical Group
Market Cap: HK$28.2b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.04
7D
0.8%
1Y
79.9%
China Medical System Holdings
Market Cap: HK$33.0b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.64
7D
4.4%
1Y
87.1%
China Resources Pharmaceutical Group
Market Cap: HK$29.0b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.61
7D
2.9%
1Y
-14.3%